Not Yet RecruitingNot Applicable

Effect of Functional Magnetic Therapy on Constipation Predominant- Irritable Bowel Syndrome (IBS-C)

Egypt50 participantsStarted 2025-11-28

Plain-language summary

The aim of this study is to evaluate the potential benefits of functional magnetic therapy on constipation improvement and related symptoms in patients with IBS-C, including abdominal pain, bloating, bowel habits, and quality of life, as well as to assess patient satisfaction and experience with the therapy.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Diagnosis of IBS-C based on Rome IV criteria.
✓. Age: Adults aged 18-65 years.
✓. Symptom Duration: Symptoms present for at least 6 months before diagnosis.
✓. Ability to Consent: Patients must be able to provide informed consent and comply with study requirements.

Exclusion criteria

✕. Presence of Alarm Features or Red Flags:
✕. Underlying Organic Diseases:
✕. Pregnancy or Lactation.
✕. Surgery or Anatomic Alterations: History of major gastrointestinal surgeries (e.g., bowel resection) that could affect bowel function.
✕. Contraindications to the Procedure:

What they're measuring

IBS Severity Scoring System (IBS-SSS)

Timeframe: 8 weeks

Complete Spontaneous Bowel Movements (CSBMs)

Timeframe: 8 weeks

Bristol Stool Scale Assessment (BSS)

Timeframe: 8 weeks

Trial details

NCT IDNCT07256262

SponsorBeni-Suef University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-01-28

Contact for this trial

Amira Ali Gaber Ali, B.Sc

+20 102 366 0326 Amira.ali_2160218@student.deraya.edu.eg

View on ClinicalTrials.gov More Irritable Bowel Syndrome trials